Prostatic adenocarcinoma. Considerations in management

D. A. Pistenma, M. A. Bagshaw

Research output: Contribution to journalArticlepeer-review


Management of prostatic adenocarcinoma depends on the extent of disease as determined by staging procedures: digital rectal examination, histologic grading of the tissue specimen, and evaluation for dissemination of disease to bone and other distant sites. At this time there is no curative treatment for patients with widespread bone or visceral metastases. When the cancer is histologically confined to the gland and there are no lymph node or other metastases, total prostatectomy should be curative. Other therapeutic options with comparable success are external beam radiation and interstitial implantation of iodine 125 radioactive seeds. Pelvic lympho node dissection is appropriately used to assess the status of nodes prior to prostatectomy or implantation of radioactive seeds. Its therapeutic effectiveness has not yet been proved.

Original languageEnglish (US)
Pages (from-to)135-145
Number of pages11
JournalPostgraduate medicine
Issue number4
StatePublished - Jan 1 1980

ASJC Scopus subject areas

  • General Medicine


Dive into the research topics of 'Prostatic adenocarcinoma. Considerations in management'. Together they form a unique fingerprint.

Cite this